(Q42248079)

19 October 2017

title

Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis (English)

1 reference

19 October 2017

main subject

visceral leishmaniasis

1 reference

Rajan Guha

1

1 reference

19 October 2017

Deepika Gupta

2

1 reference

19 October 2017

Ruchir Rastogi

3

1 reference

19 October 2017

Rajagopal Vikram

4

1 reference

19 October 2017

Ganga Krishnamurthy

5

1 reference

19 October 2017

Sanjiva Bimal

6

1 reference

19 October 2017

Syamal Roy

7

1 reference

19 October 2017

Amitabha Mukhopadhyay

8

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 September 2013

1 reference

Science Translational Medicine

19 October 2017

published in

1 reference

19 October 2017

volume

5

1 reference

19 October 2017

issue

202

1 reference

19 October 2017

page(s)

202ra121

1 reference

Leishmaniasis: current treatment and prospects for new drugs and vaccines

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Determinants for the development of visceral leishmaniasis disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Leishmaniasis: complexity at the host-pathogen interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Leishmaniasis: vaccine candidates and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Antileishmanial drug development: exploitation of parasite heme dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Rab5-mediated endosome-endosome fusion regulates hemoglobin endocytosis in Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Leishmania requires Rab7-mediated degradation of endocytosed hemoglobin for their growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Clathrin-mediated hemoglobin endocytosis is essential for survival of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Hemoglobin receptor in Leishmania is a hexokinase located in the flagellar pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Compartmentation of carbohydrate metabolism in trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

The immunopathology of experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generati

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

T-bet regulates T-independent IgG2a class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Vaccines against intracellular infections requiring cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

A human multi-epitope recombinant vaccinia virus as a universal T cell vaccine candidate against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Recombinant interleukin 12 cures mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

Heme as a source of iron to Leishmania infantum amastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006406

10.1126/SCITRANSLMED.3006406

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference